Trial Condition(s):

Clinical Pharmacology

Drug-drug interaction study to investigate the effect of finerenone on warfarin

Bayer Identifier:

14503

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2014-001832-13

Study Completed

Trial Purpose

The primary objective of this study was to investigate whether, with respect to warfarin, there is any pharmacodynamic or pharmacokinetic interaction when finerenone and warfarin are co-administered in healthy subjects.
The secondary objectives were the investigation of the pharmacokinetics of finerenone alone and after concomitant administration with warfarin, as well as the assessment of safety and tolerability of these treatments.

Inclusion Criteria
- Healthy White male subjects 18-45 years of age (inclusive)
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
32
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
Yes
Products
Kerendia (Finerenone, BAY94-8862)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Berlin, Germany, 13353

Status
Completed
 

Trial Design